Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Helios BioSciences

The quick selection at low cost of relevant therapeutic targets is one of today major challenges facing the Biotech companies and pharmaceutical industry. The evaluation of the genes involved in a given pathology is a privileged axis for the identification of new therapeutic targets.Helios Biosciences proposes a new paradigm to effectively characterize therapeutic targets, : the dynamic modeling of molecular cascades of signal transductions.


Contact Details:
8, avenue du Général Sarrail
Créteil
Cedex
94010
France
Tel:33 1 49 81 37 92
Fax:
Email:info@heliosbiosciences.com
WWW:

www.heliosbiosciences.com/




BioNews Results for Helios BioSciences:

Week of Sept. 7, 2009: Facet Rejects Biogen Idec's Proposal; Roche Announces Management Changes; More
Pharmaceutical Technology:  Sep 10 2009 5:48PM Matching: helios biosciences

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 271 times since April 2007, the link to the organisation's website has been followed 67 times

Search for more companies in Créteil

Search for more companies in Cedex



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Helios BioSciences

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.